MedPath

POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE

POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE

Approved
Approval ID

1a01d41b-3da1-4938-9e71-499320c72dd2

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 11, 2023

Manufacturers
FDA

DIRECT RX

DUNS: 079254320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61919-233
Application NumberNDA050567
Product Classification
M
Marketing Category
C73605
G
Generic Name
POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJanuary 11, 2023
FDA Product Classification

INGREDIENTS (7)

WATERInactive
Code: 059QF0KO0R
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
POLYMYXIN B SULFATEActive
Quantity: 10000 [USP'U] in 1 mL
Code: 19371312D4
Classification: ACTIM
TRIMETHOPRIM SULFATEActive
Quantity: 1 mg in 1 mL
Code: E377MF8EQ8
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

POLYMYXIN B SULFATE AND TRIMETHOPRIM SULFATE - FDA Drug Approval Details